Κυριακή 8 Αυγούστου 2021

T1 glottic laryngeal cancer: the role of routine follow-up visits in detecting local recurrence

xlomafota13 shared this article with you from Inoreader

Eur Arch Otorhinolaryngol. 2021 Aug 6. doi: 10.1007/s00405-021-06983-3. Online ahead of print.

ABSTRACT

PURPOSE: We assessed the treatment outcome and the benefits of routine follow-up visits in T1 glottic laryngeal squamous cell carcinoma (LSCC).

METHODS: Medical records of patients diagnosed with stage T1 glottic LSCC (N = 303) in five Finnish university hospitals between 2003 and 2015 were reviewed. Moreover, data from the Finnish Cancer Registry and the Population Register Center were collected.

RESULTS: Of all 38 recurrences, 26 (68%) were detected during a routine follow-up visit, and over half (21 of 38, 55%) presented without new symptoms. Primary treatment method (surgery vs. radiotherapy) was not connected with 5-year disease-specific survival (DSS) or laryngeal preservation rate.

CONCLUSION: The majority of recurrences were detected on a routine follow-up visit, and local recurrences often presented without new symptoms. Routine post-treatment follow-up of T1 glottic LSCC seems beneficial.

TRIAL REGISTRATION: Trial registration number and date of registration HUS/356/2017 11.12.2017.

PMID:34357460 | DOI:10.1007/s00405-021-06983-3

View on the web

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου